首页> 美国卫生研究院文献>Journal of Virology >Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.
【2h】

Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.

机译:CD8 +细胞抑制人类1型免疫缺陷病毒复制:HLA I类限制的溶细胞和非溶细胞机制触发的证据。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although CD8+ lymphocytes in human immunodeficiency virus type 1 (HIV-1)-infected individuals have been demonstrated to suppress viral replication, the mechanisms of inhibition have not been defined precisely. A large body of evidence indicates that these cells act via soluble inhibitory factors, but the potential role of HLA class I-restricted cytolysis has remained controversial. Here we demonstrate that HIV-1-specific cytotoxic T lymphocytes (CTL) mediate antiviral suppression by both cytolytic and noncytolytic mechanisms. The predominant mechanism requires direct contact of CTL with the infected cells, is HLA class I restricted, and can achieve complete elimination of detectable virus in infected cell cultures. Inhibition occurs even at high multiplicities of infection or at ratios of CTL to CD4 cells as low as 1:1,000. The other mechanism is mediated by soluble inhibitory factors which are triggered in an antigen-specific and HLA-restricted fashion but then act without HLA restriction. These include MIP-1alpha, MIP-1beta, and RANTES, as well as a distinct factor(s) capable of inhibiting HIV-1 strains insensitive to these chemokines. These data indicate that HIV-1-specific CTL are potent mediators of HIV-1 suppression at cell ratios existing in vivo and demonstrate an antigen-specific trigger for CD8+ cell-derived soluble inhibitory factors. These results suggest that CTL play an important role in the observed antiviral activity of CD8+ cells from infected individuals.
机译:尽管已证明人类免疫缺陷病毒1型(HIV-1)感染者中的CD8 +淋巴细胞可抑制病毒复制,但其抑制机理尚未精确定义。大量证据表明,这些细胞通过可溶性抑制因子发挥作用,但HLA I类限制性细胞溶解的潜在作用仍存在争议。在这里,我们证明HIV-1特异性细胞毒性T淋巴细胞(CTL)通过溶细胞和非溶细胞机制介导抗病毒抑制作用。主要机制要求CTL与感染细胞直接接触,受到HLA I类限制,并且可以完全消除感染细胞培养物中可检测到的病毒。即使在高感染度或CTL与CD4细胞的比例低至1:1,000的情况下,也会发生抑制作用。另一机制由可溶性抑制因子介导,可溶性抑制因子以抗原特异性和HLA限制的方式触发,但随后在不受HLA限制的情况下起作用。这些包括MIP-1alpha,MIP-1beta和RANTES,以及能够抑制对这些趋化因子不敏感的HIV-1菌株的独特因子。这些数据表明,HIV-1特异性CTL在体内存在的细胞比率下是HIV-1抑制的有效介体,并证明CD8 +细胞衍生的可溶性抑制因子具有抗原特异性触发作用。这些结果表明,CTL在观察到的来自感染个体的CD8 +细胞的抗病毒活性中起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号